Indofarma Tbk. vs Sinergi Inti Andalan Prima Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Sinergi Inti Andalan Prima Tbk. trades at Rp344 (market cap 7.74T, 668.43M 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 19.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | INET | |
|---|---|---|
Market Cap | 390.51B | 7.74T |
Volume | — | 668.43M |
Lot | — | 6.68M |
Turnover | — | 223.38B |
Average Price | — | 334.19 |
Value | — | 223.38B |
Indicative Equilibrium Price | — | 344 |
Indicative Equilibrium Volume | — | 105.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Read more on INET →